Icon
+91 94997 68112
Login Register

MEDROL ACETATE (nda012421)- (0.25%,1%)

METHYLPREDNISOLONE ACETATE PHARMACIA AND UPJOHN
0.25%,1%
No No
Expired Expired
None None
None No
MEDROL Tablets are indicated in the following conditions: 1. Endocrine Disorders 2. Rheumatic Disorders 3. Collagen Diseases 4. Dermatologic Diseases 5. Allergic States 6. Ophthalmic Diseases 7. Respiratory Diseases 8. Hematologic Disorders 9. Neoplastic Diseases 10. Edematous States 11. Gastrointestinal Diseases 12. Nervous System.
0 0 0
Total Other Developers None
Drugs with Suitability No
0.25% ** ** - - -
1% ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report

Download GenUS Detailed Report

To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.